The levels of glucose transporter 1 (GLUT1) have been demonstrated to increase upon TGFβ stimulation in mesangial cells, breast cancer cells, glioma cells and pancreatic ductal adenocarcinoma [73–76] (Fig. 2). Here, SLC2A1 is linked to breast carcinoma.